PSB Holdings Inc. Announces Q4 2024 Earnings of $0.73 per Share, Boosting Annual Profits by 10% to $2.37

PSB Holdings Reports Strong Fourth Quarter Earnings Wausau, WI – PSB Holdings, Inc. (PSB), the parent company of Peoples State Bank, announced impressive financial results for the fourth quarter of 2024. The company reported earnings of $0.73 per common share on net income of $3.0 million, marking a significant increase from the third quarter’s earnings…

Read More

“Revolutionizing Hospitality: XTM’s AnyDay™ Offers Instant Wage Access and Tip Calculator Solution, Demand Skyrockets with ‘No Tax on Tips’ Proposal”

XTM Inc. Experiencing Surge in Interest for AnyDay™ Earned Wage Access Platform TORONTO–(BUSINESS WIRE)–XTM Inc. (“XTM” or the “Company”) (OTC: XTMIF / CSE: PAID / FSE: 7XT), a fintech innovator specializing in payment solutions for the hospitality industry, is experiencing a surge in inbound interest for its AnyDay™ Earned Wage Access (EWA) platform and instant…

Read More

Sunnova’s Solar Storage Solution Chosen for Beazer Homes’ Innovative VISION House Project

Sunnova Unveils Zero Energy Ready Home with Solar and Battery Storage at VISION House Las Vegas Sunnova Energy International Inc., a pioneering adaptive energy services company, recently showcased a solar and battery storage-integrated Zero Energy Ready Home (ZERH) at Green Builder Media’s VISION House Las Vegas. This innovative residence is part of the VISION House…

Read More

AVAX: Riding the Crypto Avalanche to Success – Market Cap Skyrockets by 344%!

AVAX: Riding the Crypto Avalanche to Success – Market Cap Skyrockets by 344%! Introduction Avalanche (AVAX), the blockchain platform known for its scalability and infrastructure, made significant strides in the fourth quarter (Q4) of 2023. According to a report by Messari, AVAX emerged as one of the best-performing tokens, driving the protocol to record notable…

Read More

Decoding Arcutis Biotherapeutics’ Q4 2024 Earnings Call: Insights from the Transcript

Arcutis Biotherapeutics’ Q4 2024 Earnings Call: Key Highlights On February 25, 2025, Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) held its fourth quarter and full year financial results conference call. The call was led by Latha Vairavan, Vice President of Finance and Investor Relations, and featured presentations from Frank Watanabe, President and CEO; Todd Edwards, Chief Commercial…

Read More